Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Renal Cell 65Sarcoma 40Neoplasm Metastasis 22Neoplasms 20Ovarian Neoplasms 17Breast Neoplasms 17Carcinoma, Non-Small-Cell Lung 15Recurrence 7Leiomyosarcoma 7Kidney Neoplasms 7Melanoma 6Liposarcoma 6Hemangiosarcoma 6Glioblastoma 6Fallopian Tube Neoplasms 6Thyroid Neoplasms 5Prostatic Neoplasms 5Neurofibrosarcoma 5Lung Neoplasms 5Urinary Bladder Neoplasms 4Solid Tumors 4Sarcoma, Synovial 4Pancreatic Neoplasms 4Osteosarcoma 4Histiocytoma, Malignant Fibrous 4Dermatofibrosarcoma 4Clear-cell metastatic renal cell carcinoma 4Chondrosarcoma, Extraskeletal Myxoid 4Uterine Cervical Neoplasms 3Small Cell Lung Carcinoma 3

Interventions

Standard of Care 2tocilizumab 1pazopanib 1Tomography, X-Ray Computed 1Practice Guidelines as Topic 1Operative Blood Salvage 1Molecular Imaging 1Methods 1Magnetic Resonance Spectroscopy 1Lenalidomide 1Interviews as Topic 1Immunoglobulin G 1High-Energy Shock Waves 1Educational Status 1Early Intervention, Educational 1Disulfides 1Cardiac Surgical Procedures 1Breathing Exercises 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Coronary Artery Disease × pazopanib × Clear all
NCT01446224 2015-03-27

Cardiovascular and Torsades de Pointes Monitoring for Pazopanib

GlaxoSmithKline

Completed
1 enrolled
Genitourinary

Carcinoma, Renal Cell, Coronary Artery Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡